Antisense MBD2 gene therapy inhibits tumorigenesis

Andrew Slack, Veronica Bovenzi, Pascal Bigey, M. A. Ivanov, Shyam Ramchandani, Sanjoy K Bhattacharya, Benjamin tenOever, B. Lamrihi, Daniel Scherman, Moshe Szyf

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Aberration in the pattern of DNA methylation is one of the hallmarks of cancer. We present data suggesting that dysregulation of MBD2, a recently characterized member of a novel family of methylated DNA binding proteins, is involved in tumorigenesis. Two functions were ascribed to MBD2, DNA demethylase activity and repression of methylated genes. Methods: Multiple antisense expression and delivery systems, transfection, electrotransfer and adenoviral were employed to demonstrate that MBD2 is essential in tumorigenesis, both ex vivo and in vivo. Results: Inhibition of MBD2 by antisense expression resulted in inhibition of anchorage-independent growth of antisense transfected cancer cells or cells infected with an adenoviral vector expressing MBD2 antisense. Xenograft tumors treated with an adenoviral vector expressing MBD2 antisense or xenografts treated with electrotransferred plasmids expressing MBD2 antisense showed reduced growth. Conclusions: These results support the hypothesis that one or both of the functions described for MBD2 are critical in tumorigenesis and that MBD2 is a potential anticancer target.

Original languageEnglish
Pages (from-to)381-389
Number of pages9
JournalJournal of Gene Medicine
Volume4
Issue number4
DOIs
StatePublished - Jul 1 2002
Externally publishedYes

Fingerprint

Genetic Therapy
Carcinogenesis
Heterografts
Neoplasms
DNA-Binding Proteins
DNA Methylation
Growth
Transfection
Plasmids
DNA
Genes

Keywords

  • Adenoviral vectors
  • Antisense
  • Demethylase
  • DNA methylation
  • Methylated DNA binding proteins
  • Tumorigenesis

ASJC Scopus subject areas

  • Genetics

Cite this

Slack, A., Bovenzi, V., Bigey, P., Ivanov, M. A., Ramchandani, S., Bhattacharya, S. K., ... Szyf, M. (2002). Antisense MBD2 gene therapy inhibits tumorigenesis. Journal of Gene Medicine, 4(4), 381-389. https://doi.org/10.1002/jgm.288

Antisense MBD2 gene therapy inhibits tumorigenesis. / Slack, Andrew; Bovenzi, Veronica; Bigey, Pascal; Ivanov, M. A.; Ramchandani, Shyam; Bhattacharya, Sanjoy K; tenOever, Benjamin; Lamrihi, B.; Scherman, Daniel; Szyf, Moshe.

In: Journal of Gene Medicine, Vol. 4, No. 4, 01.07.2002, p. 381-389.

Research output: Contribution to journalArticle

Slack, A, Bovenzi, V, Bigey, P, Ivanov, MA, Ramchandani, S, Bhattacharya, SK, tenOever, B, Lamrihi, B, Scherman, D & Szyf, M 2002, 'Antisense MBD2 gene therapy inhibits tumorigenesis', Journal of Gene Medicine, vol. 4, no. 4, pp. 381-389. https://doi.org/10.1002/jgm.288
Slack A, Bovenzi V, Bigey P, Ivanov MA, Ramchandani S, Bhattacharya SK et al. Antisense MBD2 gene therapy inhibits tumorigenesis. Journal of Gene Medicine. 2002 Jul 1;4(4):381-389. https://doi.org/10.1002/jgm.288
Slack, Andrew ; Bovenzi, Veronica ; Bigey, Pascal ; Ivanov, M. A. ; Ramchandani, Shyam ; Bhattacharya, Sanjoy K ; tenOever, Benjamin ; Lamrihi, B. ; Scherman, Daniel ; Szyf, Moshe. / Antisense MBD2 gene therapy inhibits tumorigenesis. In: Journal of Gene Medicine. 2002 ; Vol. 4, No. 4. pp. 381-389.
@article{3ff93d682e23406faa59e441c0ef5bea,
title = "Antisense MBD2 gene therapy inhibits tumorigenesis",
abstract = "Background: Aberration in the pattern of DNA methylation is one of the hallmarks of cancer. We present data suggesting that dysregulation of MBD2, a recently characterized member of a novel family of methylated DNA binding proteins, is involved in tumorigenesis. Two functions were ascribed to MBD2, DNA demethylase activity and repression of methylated genes. Methods: Multiple antisense expression and delivery systems, transfection, electrotransfer and adenoviral were employed to demonstrate that MBD2 is essential in tumorigenesis, both ex vivo and in vivo. Results: Inhibition of MBD2 by antisense expression resulted in inhibition of anchorage-independent growth of antisense transfected cancer cells or cells infected with an adenoviral vector expressing MBD2 antisense. Xenograft tumors treated with an adenoviral vector expressing MBD2 antisense or xenografts treated with electrotransferred plasmids expressing MBD2 antisense showed reduced growth. Conclusions: These results support the hypothesis that one or both of the functions described for MBD2 are critical in tumorigenesis and that MBD2 is a potential anticancer target.",
keywords = "Adenoviral vectors, Antisense, Demethylase, DNA methylation, Methylated DNA binding proteins, Tumorigenesis",
author = "Andrew Slack and Veronica Bovenzi and Pascal Bigey and Ivanov, {M. A.} and Shyam Ramchandani and Bhattacharya, {Sanjoy K} and Benjamin tenOever and B. Lamrihi and Daniel Scherman and Moshe Szyf",
year = "2002",
month = "7",
day = "1",
doi = "10.1002/jgm.288",
language = "English",
volume = "4",
pages = "381--389",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Antisense MBD2 gene therapy inhibits tumorigenesis

AU - Slack, Andrew

AU - Bovenzi, Veronica

AU - Bigey, Pascal

AU - Ivanov, M. A.

AU - Ramchandani, Shyam

AU - Bhattacharya, Sanjoy K

AU - tenOever, Benjamin

AU - Lamrihi, B.

AU - Scherman, Daniel

AU - Szyf, Moshe

PY - 2002/7/1

Y1 - 2002/7/1

N2 - Background: Aberration in the pattern of DNA methylation is one of the hallmarks of cancer. We present data suggesting that dysregulation of MBD2, a recently characterized member of a novel family of methylated DNA binding proteins, is involved in tumorigenesis. Two functions were ascribed to MBD2, DNA demethylase activity and repression of methylated genes. Methods: Multiple antisense expression and delivery systems, transfection, electrotransfer and adenoviral were employed to demonstrate that MBD2 is essential in tumorigenesis, both ex vivo and in vivo. Results: Inhibition of MBD2 by antisense expression resulted in inhibition of anchorage-independent growth of antisense transfected cancer cells or cells infected with an adenoviral vector expressing MBD2 antisense. Xenograft tumors treated with an adenoviral vector expressing MBD2 antisense or xenografts treated with electrotransferred plasmids expressing MBD2 antisense showed reduced growth. Conclusions: These results support the hypothesis that one or both of the functions described for MBD2 are critical in tumorigenesis and that MBD2 is a potential anticancer target.

AB - Background: Aberration in the pattern of DNA methylation is one of the hallmarks of cancer. We present data suggesting that dysregulation of MBD2, a recently characterized member of a novel family of methylated DNA binding proteins, is involved in tumorigenesis. Two functions were ascribed to MBD2, DNA demethylase activity and repression of methylated genes. Methods: Multiple antisense expression and delivery systems, transfection, electrotransfer and adenoviral were employed to demonstrate that MBD2 is essential in tumorigenesis, both ex vivo and in vivo. Results: Inhibition of MBD2 by antisense expression resulted in inhibition of anchorage-independent growth of antisense transfected cancer cells or cells infected with an adenoviral vector expressing MBD2 antisense. Xenograft tumors treated with an adenoviral vector expressing MBD2 antisense or xenografts treated with electrotransferred plasmids expressing MBD2 antisense showed reduced growth. Conclusions: These results support the hypothesis that one or both of the functions described for MBD2 are critical in tumorigenesis and that MBD2 is a potential anticancer target.

KW - Adenoviral vectors

KW - Antisense

KW - Demethylase

KW - DNA methylation

KW - Methylated DNA binding proteins

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=13644255586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13644255586&partnerID=8YFLogxK

U2 - 10.1002/jgm.288

DO - 10.1002/jgm.288

M3 - Article

C2 - 12124980

AN - SCOPUS:13644255586

VL - 4

SP - 381

EP - 389

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 4

ER -